Many thanks to Sanofi to join BioFIT 2017 as a Gold Sponsor!

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people they serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare.

Join key BioFIT 2017 sponsors such as PfizerBayerLillyRocheMSDMerckBoehringer IngelheimJohnson & Johnson Innovation, Novo NordiskLFBPPRS and Trianni to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Bernd STOWASSER, Head of European Public Private Partnerships at SANOFI Germany will join BioFIT as a speaker and discuss latest issues on Big consortia: how they work and what are their outcomes.

Many companies and research institutes are getting more and more involved in consortia of different sizes in order to work together around specific questions they are all looking to find an answer to. Of course their organization can be very different depending on the number of partners involved and the questions addressed. But how can their outcomes be evaluated, knowing that what comes out is non-tangible knowledge which itself is later used in other R&D processes in order to obtain real results? Moreover, what type of guidance is necessary in order make them work and obtain successful outcomes?

Come learn more and discuss with our speakers on December 2nd at 9am.

Moderator: Hugh LAVERTY, Senior Scientific Project Manager, IMI – Innovative Medicines Initiative (BE)

Speakers:

  • Bernd STOWASSER, Head of Public Private Partnerships – External Innovation & Science Policy, Sanofi (DE)
  • Nicolas CARBONI, President, SATT Conectus Alsace (FR)
  • Jacky VONDERSCHER, President, Enyo Pharma (FR)
  • Bruno FRANCOIS, Clinical Lead COMBACTE Consortium, CHU Limoges/Inserm (FR)

Check full agenda

Check speakers